Manufacturer record
Sarv Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by Sarv Pharmaceuticals (Uttarakhand) were declared Not of Standard Quality between April 2025 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 379AB04, Bupropion Hydrochloride Extended Release Tablets IP 150 mg (exp Sep 2026). DTL, Delhi (state lab) found it not of standard quality: Test For Description & Assay (Content) Of Bupropion Hydrochloride. Listed in the August 2026 alert.
Records by type
6 records linked to Sarv Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Bupropion Hydrochloride Extended Release Tablets IP 150 mg | Batch 379AB04Mfg Oct 2024 · Exp Sep 2026 | Test For Description & Assay (Content) Of Bupropion HydrochlorideAssay | DTL, DelhiState lab | Aug 2026 |
| Benfotiamine Methylcobalamin Alpha Lipoic Acid Folic Acid Chromium Picolinate Myo Inositol & Pyridoxine Hydrochloride Tablets | Batch 29AW27Mfg Jan 2025 · Exp Jun 2026 | DisintegrationDisintegration | RDTL, Bellary, KarnatakaState lab | May 2026 |
| Metoprolol Succinate (ER) & Amlodipine Besylate Tablets IP (Metorell-AM 50 Tablets) | Batch 77BG08Mfg Jun 2025 · Exp May 2027 | Uniformity of Weight? and ?Test for Dissolution for AmlodipineDissolution | DTL, Bengaluru, KarnatakaState lab | Oct 2025 |
| Metoprolol Succinate (ER) & Amlodipine Besylate Tablets IP (Metorell-AM50) Tablets | Batch 77BG06Mfg Jun 2024 · Exp May 2026 | Identification test for Metoprolol Succinate and Assay for Metoprolol SuccinateAssay | KarnatakaState lab | Jul 2025 |
| Paracetamol Tablets I.P 500mg(Fevimed) | Batch 451AA05Mfg Dec 2023 · Exp Nov 2025 | The sample does not comply for Description as, the tablets shows uneven light Brown Coloured Spots on the Surface of almost all the Tablets.Description | N.S. Bhalerao, Hingoli , FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab | May 2025 |
| Fevimed (Paracetamol tablets IP 500 mg) | Batch 451AA05Mfg Dec 2023 · Exp Nov 2025 | The Sample does not comply for description as the tablets shows light brown coloured spots on the surface of almost all the tabletsDescription | State Lab MaharashtraState lab | Apr 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.